Cancer Biology & Genetics Program

The Tuomas Tammela Lab

Tuomas Tammela, MD, PhD

Associate Member, Cancer Biology & Genetics Program, MSKCC

The Tammela lab is interested in understanding the remarkable phenotypic heterogeneity of cancer cells within tumors. We approach this question using a combination of sophisticated genetically engineered mouse models, single-cell approaches, tracing and ablation of distinct tumor cell lineages, CRISPR-mediated gene regulation, and advanced imaging techniques. We utilize the exceptional resources developed by our MSK collaborators, such as organoids and xenografts, for the translation of our findings into new treatments for human cancer. Our goal is to discover pathways that drive distinct cellular phenotypes and to develop new therapeutic concepts aimed at reducing cellular heterogeneity in tumors.

Research Projects

Understanding Cellular Heterogeneity in Cancer

VIDEO | 01:57

Inside My Lab: Tuomas Tammela

Go inside the lab of Tuomas Tammela from SKI’s Cancer Biology & Genetics Program.

Video Details

Featured News

At Work: Cancer Biologist Tuomas Tammela

Cancer biologist Tuomas Tammela discusses his path to becoming a cancer researcher and the focus of his lab.

Finding

A Never-Before-Seen Cell State May Explain Cancer’s Ability to Resist Drugs

Thursday, July 23, 2020

Identified in mice, this unusual cell state emerges early during tumor evolution and gives tumors enormous malleability.

Publications

Marjanovic ND, Hofree M, Chan JE, Canner D, Wu K, Trakala M, Hartmann GG, Smith OC, Kim JY, Evans KV, Hudson A, Ashenberg O, Porter CBM, Bejnood A, Subramanian A, Pitter K, Yan Y, Delorey T, Phillips DR, Shah N, Chaudhary O, Tsankov A, Hollmann T, Rekhtman N, Massion PP, Poirier JT, Mazutis L, Li R, Lee JH, Amon A, Rudin CM, Jacks T, Regev A, Tammela T. Emergence of a High-Plasticity Cell State during Lung Cancer Evolution. Cancer Cell, 38(2):229-246 (2020).

Tammela T, Sanchez-Rivera FJ, Malli-Cetinbas N, Joshi NS, Helenius K, Park YK, Azimi R, Wu K, Kerper NR, Wesselhoeft RA, Gu X, Schmidt L, Cornwall-Brady M, Yilmaz ÖH, Xue W, Katajisto P, Bhutkar A, and Jacks T. A Wnt-producing niche drives proliferative potential and progression in lung adenocarcinoma. Nature, 545:355-359 (2017).

Roper J*, Tammela T*, Cetinbas N, Akkad A, Almeqdadi M, Wu K, Sánchez-Rivera F, Rickelt S, Park Y, Liang X, Oberli M, Eng G, Roghanian A, Azimi R, Kedrin D., Neupane R., Beyaz S., Sicinska E.T., Bass A., Suarez Y., Yoo J., Chen L., Taylor M.S., Zukerberg L., Katajisto P., Lees J., Deshpande V., Chen J., Hynes R.O., Langer R., Bhutkar A.J., Jacks T., Yilmaz. Ö.H. Epithelial genome editing and orthotopic transplantation models of sequential mutagenesis in colorectal cancer. Nature Biotechnology, 3:569–576 (2017).

View All Publications

People

Tuomas Tammela, MD, PhD

Associate Member, Cancer Biology & Genetics Program, MSKCC

Cancer biologist Tuomas Tammela investigates cellular heterogeneity in lung and pancreatic cancers.
Massachusetts Institute of Technology: Postdoctoral Fellowship
University of Helsinki, Finland: MD, PhD

646-888-2048: Office Phone

Members

Photo of Heather Alcorn — Heather Alcorn
Lab Manager

Photo of Klavdija Bastl — Klavdija Bastl
GSK Graduate Student; Harold Varmus Scholar in Cancer Biology; Boehringer Ingelheim Fond PhD Fellow

Emma Brown

Research Technician

Jason Chan, MD, PhD — Jason Chan
Clinical Instructor

Photo of Selena Ding — Selena Ding
Research Technician

Mandy Montemoíño

Administrative Assistant

Photo of Chun-Hao Pan — Chun-Hao Pan
Postdoctoral Fellow

Eliud Rivas Hernandez

MSK Bridge Scholar

Photo of Dr. Anupriya Singhal — Anupriya Singhal
Clinical Fellow

Hannah Styers, BS — Hannah Styers
Research Technician

Stefan Torborg
MD-PhD Student; Kirschstein National Research Service Award (F30) Fellow

Xueqian Zhuang, PhD — Xueqian Zhuang
Postdoctoral Fellow; NYSTEM Training Award at the Center for Stem Cell Biology (CSCB)

Lab Alumni

Melissa Blum, BS — Melissa Blum
M.D. Student, Icahn School of Medicine at Mount Sinai

Alexander Ferrena
Ph.D. Student, Computational Biology Program, Albert Einstein College of Medicine

Olivera Grbovic-Huezo
Senior Principal Scientist, Clinical Biomarker Development at Loxo Oncology/Lilly

Photo of Mikel Gregory — Mikel Gregory
BRIDGE Program Post-Baccalaureate trainee

Griffin Hartmann, BS — Griffin Hartmann
Ph.D. Student, Stanford University

Matilda Holm
Postdoctoral Fellow, Karolinska Institute, Sweden

Anna Hudson
M.D./Ph.D. Student, University of Miami

Emily B. Johnson, MPH — Emily B. Johnson
Clinical Research Project Coordinator, MSKCC Pediatrics

Simon Joost, PhD — Simon Joost
Postdoctoral Researcher

Ken Pitter, MD, PhD — Ken Pitter
Assistant Professor, Department of Radiation Oncology, OSUCCC, Columbus, Ohio

Carleigh Sussman, BS — Carleigh Sussman
Research Associate, RenBio

Katherine Wu, BS Senior Research Technician — Katherine Wu
M.D./Ph.D. Student, New York University

Yan Yan
Assistant Professor, Huazhong Agricultural University

Lab Affiliations

Achievements

Josie Robertson Investigator (2017-2022)
The Mark Foundation Emerging Leader Award (2021)
Rita Allen Foundation Scholar (2020)
National Cancer Institute R37 MERIT Award (2020)
American Cancer Society Scholar (2020)

V Foundation Scholar (2019)

Open Positions

To learn more about available postdoctoral opportunities, please visit our Career Center

To learn more about compensation and benefits for postdoctoral researchers at MSK, please visit Resources for Postdocs

Career Opportunities

Apply now

Get in Touch

646-888-2048

Office Phone
646-888-3857

Lab Phone

Disclosures

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Tuomas Tammela discloses the following relationships and financial interests:

Lime Therapeutics, Inc.
Equity; Professional Services and Activities

The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.

This page and data include information for a specific MSK annual disclosure period (January 1, 2022 through disclosure submission in spring 2023). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].

View all disclosures